Affiliation:
1. Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
Abstract
Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination. Systematic research by geographical regions has shown that a universal treatment is far from today's reality.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference119 articles.
1. WHO. 2010. Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Technical Report Series 949. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/handle/10665/44412/WHO_TRS_949_eng.pdf?sequence=1.
2. Leishmaniasis and poverty
3. Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region
4. Leishmaniasis in immunosuppressed individuals
5. Visceral Leishmaniasis and HIV Coinfection in Latin America
Cited by
160 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献